
Grab stated it is unaware of any breach of Malaysian competition laws since its acquisition of rival Uber Technologies’s Southeast Asian operations in March last year.
The ride-hailing provider, said in a statement it acquired Uber’s Asean unit in good faith, and to provide more benefits to the public.
“Grab plays a complementary role in the entire public transportation ecosystem in Malaysia, most often serving the first-mile-last-mile needs of commuters…. Today, commuters in Malaysia continue to have the choice of getting from one point to another through public transport, street-hail taxis or more than 30 other licensed e-hailing apps,” said a Grab spokesperson.
The ride-hailing firm was responding to a Bloomberg news report, which stated that the Malaysia Competition Commission (MyCC) is advancing an anti-monopoly investigation into Grab to bring greater competition to Malaysia’s economy. Quoting Iskandar Ismail, the CEO of MyCC, the report stated the anti-monopoly watchdog was stepping up a probe into Grab, although there were no details given on the specific steps the Commission was taking.
Full Content: Deal Street Asia
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas